QT
GMAB icon

Quantbot Technologies’s Genmab GMAB Stock Holding History

Quantbot Technologies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
4,449
+613
+16% +$16.3K ﹤0.01% 1414
2026
Q1 		$103K Buy
+3,836
New +$115K ﹤0.01% 1312
2025
Q2 		– Sell
-556
Closed -$10.9K – 1736
2025
Q1 		$10.9K Buy
+556
New +$11.7K ﹤0.01% 1388
2023
Q1 		– Sell
-20,538
Closed -$870K – 1739
2022
Q4 		$870K Buy
+20,538
New +$846K 0.06% 408
2021
Q2 		– Sell
-878
Closed -$28K – 1591
2021
Q1 		$28K Sell
878
-222
-20% -$8.35K ﹤0.01% 1113
2020
Q4 		$44K Buy
1,100
+900
+450% +$33.6K ﹤0.01% 879
2020
Q3 		$7K Buy
+200
New +$7.23K ﹤0.01% 1150

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantbot Technologies's GMAB Position: Q2 2026 in Review

Quantbot Technologies increased its Genmab (GMAB) stake by 16% in Q2 2026, buying an estimated $16.3K and bringing the position to 4,449 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Quantbot Technologies first reported a position in GMAB in Q3 2020 and has held it in 7 quarters since. The position peaked at $870K in Q4 2022. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Quantbot Technologies held 4,449 shares of Genmab worth $122K as of Q2 2026.
  • Quantbot Technologies bought 613 Genmab shares in Q2 2026, an estimated $16.3K.
  • Genmab made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1414 holding.
  • Quantbot Technologies first reported a position in Genmab in Q3 2020 and has held it in 7 quarters since.
  • Quantbot Technologies's Genmab position peaked at $870K in Q4 2022.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.